YAP1 and cancer: In summary, our study identifies SIRPγ, previously considered a protein with restricted expression and function in the immune system, as a putative CSLC marker in human LUAD, and potentially many other cancers, that exerts a potent regulatory influence on the critical Hippo/YAP signaling system, providing the first molecular mechanism by which SIRPγ is engaged.